Highlight | Cancer | Genetic diseases
Angiogenesis is the formation of new blood vessels from existing blood system. Tumors promote their own vascularization. The understanding of the mechanisms that regulate angiogenesis and the identication of the key molecules involved should allow to identify new therapeutic targets in order to combat and control angiogenesis and therefore cancer. Such a molecule was characterized by a team at the Cancer Biology and Infection laboratory that inhibits the neo-angiogenesis. This molecule, BMP9, therefore representes an important tool in the pathologies where angiogenesis is implicated as in the cancer.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.